MeSH D002690 - chlamydia infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D015231:Bacterial sexually transmitted diseases
0 Companies
0 Drugs
Success rate
D002694:Chlamydiaceae infections
D002690:Â
Chlamydia infections
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| A.H. Robins Company | Erythromycin lactobionate | Erythromycin |  | 1985-03-28 |  |  |
| Erythromycin | Robimycin |  | 1982-01-01 |  |  | |
| Tetracycline | Tetracycline |  | 1982-01-01 |  |  | |
| Abbott Biotherapeutics | Erythromycin lactobionate | Erythrocin |  | 1988-01-04 |  |  |
| Tetracycline | Tetracycline |  | 1982-01-01 |  |  | |
| Alembic Pharmaceuticals | Azithromycin | Azithromycin |  | 2020-01-28 |  |  |
| Erythromycin | Erythromycin |  | 2023-08-24 |  |  | |
| Alkem Laboratories | Erythromycin | Erythromycin |  | 2022-07-13 |  |  |
| Allergan | Erythromycin estolate | Erythromycin Estolate |  | 1982-01-01 |  |  |
| Erythromycin stearate | Erythromycin Stearate |  | 1982-01-01 |  |  | |
| Tetracycline | Tetracycline |  | 1982-01-01 |  |  | |
| Alpharma | Erythromycin | Erythromycin |  | 1982-04-19 |  |  |
| Erythromycin estolate | Erythromycin Estolate |  | 1982-11-18 |  |  | |
| Erythromycin lactobionate | Erythromycin Ethylsuccinate |  | 1982-01-01 |  |  | |
| Tetracycline | Tetracycline |  | 1982-01-01 |  |  | |
| Alra | Erythromycin lactobionate, Sulfisoxazole acetyl | Eryzole |  | 1988-06-15 |  |  |
1
2
3
4
5
6
...
13
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
50%6/12
Phase 3
90%19/21
Approved: 14Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
9
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use